Age and echogenicity pattern are key independent discriminators between cardiac sarcomas and lymphomas: hypoechoic masses in younger patients favor sarcoma, whereas mixed-echoic masses in older patients suggest lymphoma, with histopathological confirmation remaining essential.
Key Findings
Results
Younger age was identified as an independent predictor of cardiac sarcoma versus lymphoma on multivariate analysis.
Odds ratio for age as predictor of sarcoma: OR 1.08 (95% CI: 1.02–1.15; p = 0.009)
The OR reflects that for each year decrease in age, the odds of sarcoma versus lymphoma increased
Study included 44 patients total: 22 sarcomas and 22 lymphomas, diagnosed between January 2010 and December 2024
All diagnoses were pathologically confirmed in this retrospective observational study
Results
Isoechoic lesion appearance on echocardiography was an independent predictor favoring cardiac sarcoma over lymphoma.
OR for isoechoic lesions as predictor of sarcoma: OR 0.09 (95% CI: 0.01–0.91; p = 0.041)
The low OR indicates that isoechoic appearance was significantly less associated with lymphoma and more with sarcoma
Echogenicity pattern was identified through univariate and multivariate logistic regression analyses
The finding implies hypoechoic or isoechoic masses are more characteristic of sarcoma, while mixed echogenicity favors lymphoma
Results
The combined model of age and echogenicity pattern demonstrated good discriminatory performance with an AUC of 0.85.
Combined model AUC: 0.85 (95% CI: 0.71–0.94)
Receiver operating characteristic curves were used to evaluate diagnostic performance
The model combined the two independently significant multivariate predictors: younger age and isoechoic lesions
This AUC suggests good but not perfect diagnostic discrimination between cardiac sarcomas and lymphomas
Results
Cardiac lymphomas more frequently exhibited mixed echogenicity compared to sarcomas.
Mixed echogenicity was present in 45.5% of lymphomas versus 13.6% of sarcomas (p = 0.016)
This finding was identified through comparative echocardiographic feature analysis
The difference in echogenicity patterns between the two tumor types was statistically significant
Echocardiographic features were systematically compared across all 44 patients
Results
Cardiac lymphomas more frequently demonstrated multi-chamber involvement compared to sarcomas.
Multi-chamber involvement was observed in 50.0% of lymphomas versus 22.7% of sarcomas (p = 0.006)
This difference was statistically significant and identified through echocardiographic comparison
Multi-chamber involvement was more than twice as common in lymphomas as in sarcomas
This feature may serve as an additional clinical clue to differentiate the two tumor types
Results
No significant difference in survival outcomes was observed between patients with cardiac sarcoma and those with cardiac lymphoma.
Log-rank p = 0.758, indicating no statistically significant difference in survival between groups
Outcomes were systematically compared as part of the retrospective observational study
Both cardiac sarcomas and lymphomas are described as rare malignant tumors with distinct treatment strategies and prognoses
The lack of survival difference was observed despite the two entities having different standard treatment approaches
Discussion
Advanced imaging may lead to potential misdiagnosis of primary cardiac malignancies, and histopathological confirmation remains essential.
The authors explicitly caution that 'clinicians should be aware of potential misdiagnosis by advanced imaging'
All 44 diagnoses in the study were pathologically confirmed, underscoring the necessity of tissue diagnosis
Accurate preoperative differentiation between sarcoma and lymphoma was described as 'clinically challenging'
Cardiac sarcomas and lymphomas have 'distinct treatment strategies and prognoses,' making accurate differentiation clinically important
What This Means
This research examined how doctors can tell the difference between two rare types of heart tumors — cardiac sarcomas and cardiac lymphomas — before surgery, using clinical information and ultrasound (echocardiography). The study looked back at 44 patients (22 with each tumor type) diagnosed over a 14-year period, all confirmed by tissue biopsy. The researchers found that two features were particularly useful for distinguishing the tumors: patient age and the appearance of the tumor on ultrasound. Sarcomas tended to occur in younger patients and appeared as uniform (isoechoic or hypoechoic) masses on ultrasound, while lymphomas were more common in older patients and showed mixed, irregular echogenicity. Lymphomas also more often involved multiple heart chambers. When these two factors were combined into a statistical model, it performed well at telling the two tumor types apart (AUC of 0.85 out of a maximum of 1.0).
Despite these differences in appearance and patient age, the survival outcomes for patients with sarcoma and lymphoma were not significantly different from each other in this study. The researchers also issued an important caution: even sophisticated imaging techniques can lead to misdiagnosis between these two types of tumors, and a tissue biopsy remains the only reliable way to confirm the diagnosis.
This research suggests that when doctors encounter a heart tumor, paying attention to the patient's age and the ultrasound appearance of the mass can provide useful clues about whether it is a sarcoma or lymphoma — information that matters because the two conditions are treated very differently. However, the findings highlight that imaging alone is insufficient, and proper tissue analysis is still required for a definitive diagnosis. Given the rarity of these tumors, larger studies will be needed to confirm these findings.